Twitter | Search | |
bluebird bio
bluebird bio is developing innovative gene therapies for severe genetic disorders. Our vision is to make the hope of gene therapy a reality.
637
Tweets
675
Following
3,851
Followers
Tweets
bluebird bio 15h
Congrats to the team at - another approval is great news for patients. We hope you're having a CAR T PAR T!
Reply Retweet Like
bluebird bio Oct 4
: Data from our Starbeam study in cerebral adrenoleukodystrophy published in
Reply Retweet Like
bluebird bio retweeted
ABPI Sep 14
Welcome to the ABPI ! The biotech becomes our 66th full member
Reply Retweet Like
bluebird bio Sep 12
Replying to @Harsiil
Hi! You can search for open opportunities on Good luck!
Reply Retweet Like
bluebird bio retweeted
ExLPharma Aug 23
Join top IR professionals from and more at the Life Science IR Forum
Reply Retweet Like
bluebird bio retweeted
Veeva Systems Aug 23
.: shares how Vault Quality streamlined processes and increased visibility with CMOs
Reply Retweet Like
bluebird bio Jul 24
Replying to @Dcwt2010
Apologies, it is a mistake. Thank you for letting us know!
Reply Retweet Like
bluebird bio Jun 28
Excited to be among 's 50 Smartest Companies for the second time!
Reply Retweet Like
bluebird bio Jun 23
Also at , the latest from our HGB-205 study:
Reply Retweet Like
bluebird bio Jun 23
announces early data from Phase 3 Northstar-2 study in pts w/ transfusion-dependent β-thalassemia:
Reply Retweet Like
bluebird bio Jun 5
and announce updated data from anti-BCMA CAR T program at
Reply Retweet Like
bluebird bio May 24
Our own Anne-Virginie Eggiman with the ARM crew! Go AV!
Reply Retweet Like
bluebird bio retweeted
ISPOR May 24
IP18 - Clark Paramore of provides the manufacturers perspective on gene therapies
Reply Retweet Like
bluebird bio May 23
We're participating in a consortium led by to develop a value-based payment framework for gene therapy
Reply Retweet Like
bluebird bio May 18
We're flying to Madrid for in June - check out what we'll be presenting:
Reply Retweet Like
bluebird bio May 17
will present updated data from anti-BCMA CAR T program at . We hope to see you there!
Reply Retweet Like
bluebird bio retweeted
Shiraz Ziya May 4
Peter Olagunju highlights distinct commercialisation challenges of personalised therapies #2022
Reply Retweet Like
bluebird bio Apr 28
Replying to @marianafagnilli
Enjoy the meeting!
Reply Retweet Like
bluebird bio Apr 21
Today, chief bluebird Nick Leschly spoke at about our commitment to patients w/ rare genetic diseases and cancer
Reply Retweet Like
bluebird bio Apr 19
Flockin' awesome! Thrilled to be among the BBJ's Best Places to Work 2017.
Reply Retweet Like